Compare TSQ & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSQ | ICCC |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 93.1M |
| IPO Year | 2014 | 1995 |
| Metric | TSQ | ICCC |
|---|---|---|
| Price | $3.81 | $10.45 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 96.7K | 7.5K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | ★ 20.94% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $427,380,000.00 | $26,493,169.00 |
| Revenue This Year | $0.67 | N/A |
| Revenue Next Year | $0.23 | N/A |
| P/E Ratio | ★ N/A | $25.80 |
| Revenue Growth | N/A | ★ 51.64 |
| 52 Week Low | $3.61 | $4.52 |
| 52 Week High | $7.97 | $12.10 |
| Indicator | TSQ | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 26.08 | 51.84 |
| Support Level | N/A | $9.45 |
| Resistance Level | $7.36 | $10.82 |
| Average True Range (ATR) | 0.24 | 0.23 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 20.19 | 51.36 |
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.